Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CALLIE NOVOSAD

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1396718144
CMS profile
11062295
Location
SAN ANTONIO, TX

General Payments · PY2021

$454.26

  • Reported across 17 records
  • CMS publication 2026-01-23

Latest program year · PY2021

$454.26

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2021 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $342.81 16
Education $111.45 1

By paying entity

PY2021 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $338.12 15
Actelion Pharmaceuticals US, Inc. $94.27 1
ACADIA Pharmaceuticals Inc $21.87 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $454.26 17

Payment records · PY2021 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2021
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ACADIA Pharmaceuticals Inc $21.87 03/03/2021 Food and Beverage Undisputed 01/23/2026 838047749 CMS
Actelion Pharmaceuticals US, Inc. $94.27 05/26/2021 Food and Beverage Undisputed 01/23/2026 788191537 CMS
Teva Pharmaceuticals USA, Inc. $14.48 01/07/2021 Food and Beverage Undisputed 01/23/2026 839538619 CMS
Teva Pharmaceuticals USA, Inc. $7.34 01/20/2021 Food and Beverage Undisputed 01/23/2026 839538621 CMS
Teva Pharmaceuticals USA, Inc. $22.92 01/25/2021 Food and Beverage Undisputed 01/23/2026 839538623 CMS
Teva Pharmaceuticals USA, Inc. $20.81 02/09/2021 Food and Beverage Undisputed 01/23/2026 839538625 CMS
Teva Pharmaceuticals USA, Inc. $7.38 03/03/2021 Food and Beverage Undisputed 01/23/2026 839538627 CMS
Teva Pharmaceuticals USA, Inc. $53.75 03/19/2021 Food and Beverage Undisputed 01/23/2026 839538629 CMS
Teva Pharmaceuticals USA, Inc. $9.36 04/02/2021 Food and Beverage Undisputed 01/23/2026 839538631 CMS
Teva Pharmaceuticals USA, Inc. $28.13 04/20/2021 Food and Beverage Undisputed 01/23/2026 839538633 CMS
Teva Pharmaceuticals USA, Inc. $9.80 04/29/2021 Food and Beverage Undisputed 01/23/2026 839538635 CMS
Teva Pharmaceuticals USA, Inc. $8.02 05/21/2021 Food and Beverage Undisputed 01/23/2026 839538637 CMS
Teva Pharmaceuticals USA, Inc. $111.45 06/28/2021 Education Undisputed 01/23/2026 839538533 CMS
Teva Pharmaceuticals USA, Inc. $13.61 06/28/2021 Food and Beverage Undisputed 01/23/2026 839538639 CMS
Teva Pharmaceuticals USA, Inc. $11.84 07/22/2021 Food and Beverage Undisputed 01/23/2026 839538641 CMS
Teva Pharmaceuticals USA, Inc. $8.04 08/27/2021 Food and Beverage Undisputed 01/23/2026 839538643 CMS
Teva Pharmaceuticals USA, Inc. $11.19 09/16/2021 Food and Beverage Undisputed 01/23/2026 839538645 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021
Source files
Dataset page · Bulk file · PY2021
Generated from
OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.